LEADER 01719nam  2200397z- 450 
001 9910689840703321
005 20161209105026.0
035   $a(CKB)5860000000034478
035   $a(BIP)012480606
035   $a(EXLCZ)995860000000034478
100   $a20220406c2005uuuu  -u-         -
101 0 $aeng
200 10$aSteroid use in professional baseball and anti-doping issues in amateur sports $ehearing before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, second session, June 18, 2002
215   $a1 online resource (iii, 53 p.) 
311   $a0-16-074709-0 
517   $aSteroid use in professional baseball and anti-doping issues in amateur sports 
606   $aAnabolic steroids$xHealth aspects$zUnited States
606   $aBaseball players$xDrug use$zUnited States
606   $aAthletes$xDrug use$zUnited States
606   $aDoping in sports$zUnited States
610   $aAnabolic steroids
610   $aBaseball players
610   $aAthletes
610   $aDoping in sports
610   $aMedical
610   $aSports & recreation
610   $aBiography & autobiography
615  0$aAnabolic steroids$xHealth aspects
615  0$aBaseball players$xDrug use
615  0$aAthletes$xDrug use
615  0$aDoping in sports
712 02$aUnited States, Congress Senate Committee on Commerce, Science, and Transportation Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism Staff,$4oth
906   $aBOOK
912   $a9910689840703321
996   $aSteroid use in professional baseball and anti-doping issues in amateur sports$93112909
997   $aUNINA